Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,478 | 147 | 99.4% |
| Education | $15.60 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $567.46 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $353.14 | 21 | $0 (2024) |
| Allergan Inc. | $298.33 | 7 | $0 (2017) |
| Novo Nordisk Inc | $207.25 | 6 | $0 (2018) |
| Lilly USA, LLC | $160.93 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $147.77 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $145.38 | 5 | $0 (2018) |
| PFIZER INC. | $119.79 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.31 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $111.09 | 26 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.50 | 7 | AstraZeneca Pharmaceuticals LP ($44.41) |
| 2023 | $104.88 | 6 | AstraZeneca Pharmaceuticals LP ($47.26) |
| 2022 | $29.84 | 2 | Cook Medical LLC ($16.59) |
| 2021 | $154.45 | 10 | GlaxoSmithKline, LLC. ($129.54) |
| 2020 | $135.58 | 9 | GlaxoSmithKline, LLC. ($61.66) |
| 2019 | $313.84 | 18 | GlaxoSmithKline, LLC. ($119.13) |
| 2018 | $275.01 | 17 | AstraZeneca Pharmaceuticals LP ($84.10) |
| 2017 | $1,364 | 82 | Allergan Inc. ($298.33) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Respiratory | ||||||
| 01/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Respiratory | ||||||
| 07/24/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardio-renal | ||||||
| 05/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: RESPIRATORY | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2022 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $16.59 | General |
| Category: Endoscopy | ||||||
| 03/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Cardiovascular | ||||||
| 07/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: RESPIRATORY | ||||||
| 01/14/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,095 | 2,003 | $336,186 | $145,957 |
| 2022 | 12 | 640 | 1,113 | $126,861 | $81,587 |
| 2021 | 11 | 770 | 1,389 | $161,718 | $105,274 |
| 2020 | 14 | 1,042 | 1,627 | $162,558 | $95,086 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 579 | $108,489 | $49,255 | 45.4% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 83 | 447 | $118,455 | $41,697 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $19,978 | $16,471 | 82.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 130 | 131 | $12,651 | $10,202 | 80.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 98 | $12,928 | $6,029 | 46.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 15 | $5,960 | $3,217 | 54.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 23 | 89 | $11,570 | $3,138 | 27.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 22 | 88 | $9,240 | $3,036 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,840 | $3,024 | 38.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 138 | 138 | $6,392 | $2,443 | 38.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 135 | 135 | $6,326 | $2,390 | 37.8% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 21 | 21 | $7,770 | $1,976 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,730 | $1,485 | 54.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 14 | 14 | $1,190 | $603.54 | 50.7% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 21 | 21 | $2,310 | $573.30 | 24.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 20 | 22 | $880.00 | $217.50 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 19 | $1,326 | $161.98 | 12.2% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 19 | 19 | $152.00 | $38.00 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 633 | $88,620 | $52,261 | 59.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 90 | 90 | $12,150 | $11,527 | 94.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 112 | $10,640 | $7,332 | 68.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $3,278 | $2,408 | 73.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 28 | 28 | $2,236 | $2,136 | 95.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,256 | $1,621 | 38.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 39 | 40 | $1,400 | $1,196 | 85.4% |
About Dr. Simrita Sidhu, MD
Dr. Simrita Sidhu, MD is a Internal Medicine healthcare provider based in Spring Hill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619938834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simrita Sidhu, MD has received a total of $2,493 in payments from pharmaceutical and medical device companies, with $115.50 received in 2024. These payments were reported across 151 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,478).
As a Medicare-enrolled provider, Sidhu has provided services to 3,547 Medicare beneficiaries, totaling 6,132 services with total Medicare billing of $427,903. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Spring Hill, FL
- Active Since 03/29/2006
- Last Updated 05/20/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619938834
Products in Payments
- TRELEGY ELLIPTA (Drug) $353.92
- FARXIGA (Drug) $256.77
- Victoza (Drug) $207.25
- ENTRESTO (Drug) $145.38
- NAMENDA XR (Drug) $139.42
- STIOLTO (Drug) $101.11
- ALLODERM (Device) $100.00
- JARDIANCE (Drug) $97.09
- ELIQUIS (Drug) $93.58
- XARELTO (Drug) $80.83
- ANORO ELLIPTA (Drug) $72.33
- ANORO (Drug) $68.04
- INVOKANA (Drug) $66.94
- BEVESPI AEROSPHERE (Drug) $64.85
- Vascepa (Drug) $62.25
- BREO (Drug) $56.08
- JANUVIA (Drug) $54.78
- TRULICITY (Drug) $42.37
- BELSOMRA (Drug) $40.48
- NAMZARIC (Drug) $35.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Spring Hill
Mr. John Batista, M.d, M.D
Internal Medicine — Payments: $92,220
Mr. Lyndon Garcia, Md, MD
Internal Medicine — Payments: $9,341
Ihab Herraka, M.d, M.D
Internal Medicine — Payments: $6,305
Dr. Gaurav Malhotra, M.d, M.D
Internal Medicine — Payments: $4,822
Dr. Rajyalakshmi Kolli, M.d, M.D
Internal Medicine — Payments: $4,583
Dinesh Keerty, M.d, M.D
Internal Medicine — Payments: $4,476